Clinical Trial Update: Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)

View source ↗

Summary

The PlacentA-DM trial investigating maternal adipose tissue and placental dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: AdventHealth Translational Research Institute | Conditions: Obesity, Type 2 Diabetes | Status: COMPLETED